Managing Acute Complications Of Sickle Cell Disease In Pediatric Patients
Sickle cell disease is a chronic hematologic disease with a variety of acute, and often recurring, complications. Vaso-occlusive crisis, a unique but common presentation in sickle cell disease, can be challenging to manage. Acute chest syndrome is the leading cause of death in patients with sickle cell disease, occurring in more than half of patients who are hospitalized with a vaso-occlusive crisis. Uncommon diagnoses in children, such as stroke, priapism, and transient red cell aplasia, occur more frequently in patients with sickle cell disease and necessitate a degree of familiarity with the disease process and its management. Patients with sickle cell trait generally have a benign course, but are also subject to serious complications. This issue provides a current review of evidence-based management of the most common acute complications of sickle cell disease seen in pediatric patients in the emergency department.
Key words: sickle cell disease, SCD, vaso-occlusive crisis, VOC, acute chest syndrome, ACS, priapism, splenic sequestration, stroke, bacteremia, febrile illness, transient red cell aplasia, sickle cell anemia, sickle cell trait, hemoglobin, pediatric, children
- Simple vaso-occlusive crisis episodes require no laboratory testing. However, if an intravenous line is to be placed or if pain is moderate/severe, a complete blood cell count (CBC) and reticulocyte count are warranted.
- Starting maintenance IV fluids is important; however, fluid boluses should only be given in hypotensive, unstable, or significantly dehydrated patients.
- In patients with sickle cell disease (SCD), normal vital signs should not be interpreted as the absence of pain. Notably, drug abuse rates in individuals with SCD are not different from the general population. If there are concerns of possible addiction, focus on treating the patient's pain, then involve the patient's hematologist as well as a pain/palliative care specialist for detailed evaluation of the patient's opioid medication use.
- Individuals with SCD are prone to reversible polymerization, or “sickling” of red blood cells during febrile, low-flow, low-oxygen, or acidotic states.
- » Download Points & PearlsNEW!
- » Download Full Topic PDF
- » Take CME Test
- » Authors And Peer Reviewers
- » Case Presentations & Case Conclusions
- » Introduction And Epidemiology
- » Critical Appraisal Of The Literature
- » Etiology And Pathophysiology
- » Differential Diagnosis
- » Prehospital Care
- » Emergency Department Evaluation
- » Diagnostic Studies
- » Management
- » Special Populations And Circumstances
- » Controversies And Cutting Edge
- » Summary
- » Risk Management Pitfalls In Pediatric Patients With Sickle Cell Disease
- » Time- And Cost-Effective Strategies
- » Clinical Pathway For Pain Management In Vaso-Occlusive Crisis In Children With Sickle Cell Disease
- » Tables And Figures
- » References
- » Sickle Cell Disease: A Comprehensive Review Of Inpatient Management - Hospital Medicine Practice - Sep 2014
- » Evidence-Based Management Of Sickle Cell Disease In The Emergency Department (FREE) - Emergency Medicine Practice - Aug 2011
- » Current Guidelines For Sickle Cell Disease: Management Of Acute Complications (FREE) - EM Practice Guidelines Update - Dec 2009
- » Sickle Cell Disease And Other Hemoglobinopathies: Approaches To Emergency Diagnosis And Treatment (FREE) - Emergency Medicine Practice - Dec 2001